scriptionbigbox="" style="box-sizing: border-box; animation-fill-mode: both; padding: 0px; margin: 0px; word-break: keep-all; position: relative; border: 1px solid rgb(240, 240, 240); width: auto; height: auto; background-color: rgb(250, 250, 250); overflow: hidden; clear: both; color: rgb(112, 112, 112); font-size: 12px; white-space: nowrap; word-wrap: break-word !import ant;">
scriptionboxb="" style="box-sizing: border-box; animation-fill-mode: both; padding: 0px; margin: 0px; word-break: keep-all; position: relative; border: none; width: auto; height: auto; clear: both; overflow: visible; word-wrap: break-word !import ant;">
scription="" p_descript ion_1="" style="box-sizing: border-box; animation-fill-mode: both; padding: 20px; margin: 0px; word-break: keep-all; width: auto; height: auto; font-size: 14px; line-height: 21px; white-space: normal; word-wrap: break-word !import ant;">
js-reset_style="" style="box-sizing: border-box; animation-fill-mode: both; padding: 0px; margin: 0px; word-break: break-all; font-family: "Microsoft Yahei", Arial, Verdana, sans-serif; word-wrap: break-word; line-height: normal; font-size: 12px;">
Cas No.:107133-36-8
Structural Formula:
Molecular Formula:C19H32N2O5·C4H11N
Brief Intro.:As ACE inhibitor used in the treatment of hypertension and heat failure etc.
Item | Standard |
Appearance | white or off-white crystalline powder |
Identification | IR, HPLC |
Specific Optical Rotation | -66°~ -69° |
Impurities A | ≤0.25% |
Impurities I | ≤0.1% |
Unknown Impurities | ≤0.1% |
Impurities E | ≤0.4% |
Impurities B | ≤0.3% |
Impurities F | ≤0.2% |
Impurities H | ≤0.2% |
Unknown Impurities | ≤0.1% |
Total Impurities | ≤1.0% |
Moisture | ≤1.0% |
Residue on ignition | ≤0.1% |
Heavy metals | ≤20ppm |
Titration Assay | 99.0%~101.0% |
Packing:25kg cardboard drum, lined with double-layer plastic bag.